The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

A disruption in federal funds has jeopardized HIV testing and outreach in Mississippi, and researchers warn of a resurgence of the epidemic.

In California, Black women are more likely to die from pregnancy-related causes than White women. Santa Clara County initiatives aimed at reducing racial disparities work but depend on federal dollars ...

Four hours without power increases odds of pediatric CO poisoning ED visit for all-scale, large-scale power outages.

HealthDay News — Twenty sessions of prefrontal-cerebellar transcranial pulsed current stimulation (tPCS) over 4 weeks in children aged 3 to 14 years with autism spectrum disorder (ASD) can improve ...

Researchers conducted a retrospective and prospective observational study to assess the effect of denosumab plus romosozumab on severe postmenopausal osteoporosis.

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

"I have tremendous confidence in the many scientists, inspectors, and staff at the FDA to help accomplish these goals and am excited to work with them," said new FDA commissioner Dr Marty Makary.

There is a difference between the terms "tardive dyskinesia" and "tardive syndrome" that clinicians should be aware of when providing care.

Food banks nationwide are being pinched by record demand, high food prices, and hundreds of millions of dollars in federal budget cuts.

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

Buprenorphine linked to reduced rate of adverse outcomes, including severe maternal morbidity, NICU admissions, and preterm births.